SBIR-STTR Award

Auto Spectral Topography for Cervical Tissue Screening
Award last edited on: 9/27/19

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$100,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Jeremy M Lerner

Company Information

LightForm Inc

601 Rte 206 Suite 26-479
Belle Meade, NJ 08876
   (908) 281-9098
   info@lightforminc.com
   www.lightforminc.com
Location: Single
Congr. District: 12
County: Somerset

Phase I

Contract Number: 1R43CA078255-01A1
Start Date: 1/1/99    Completed: 10/31/99
Phase I year
1999
Phase I Amount
$100,000
LightForm, Inc., proposes to develop an adjunct to routine Pap smear evaluation for automatic and simultaneous detection of Human Papillomavirus (HPV) and Chlamydia Trachomatis (CT) in cervicovaginal tissue. The AutoCerSpex system will enable the detection and quantification of HPV and CT by multiple fluorophore tagging. The use of Fluorescence In-Situ Hybridization (FISH) probes, type-specific for HPV, will emit in the red. CT elementary bodies will be stained by Differential ImmunoFluorescence (DIF) and will emit in the green. An inexpensive imaging spectrometer system from the space program, utilizing a proprietary Neural Network, will automatically acquire and processes spatial and spectral data to locate and map areas of infection. During Phase I, HPV 16/18 and CT will be detected to demonstrate feasibility. During Phase II, CT and multiple HPV-types, emitting many spectral features will be added to the protocol. Video images of the specimen will be simultaneously acquired for morphology and clustering analysis. The Neural Network will correlate and quantify spectra onto these images to provide a visual mapping of the incidence of HPV and CT. AutoCerSpex is a logical symbiosis of techniques known to be effective and will greatly enhance the scope of standard Pap tests. PROPOSED COMMERCIAL APPLICATION: The rapid and accurate identification of the Human Papillomavirus and Chlamydia in cervicovaginal tissue will result in earlier treatment, a reduction in loss of life and reduced in-hospital and outpatient procedures. Estimated savings could amount to 1 billion dollars per year. In addition the spectrometer could be used in many industrial applications including general life science research, semi-conductor QC, plastics, fiber optics and environmental monitoring.

Thesaurus Terms:
Chlamydia, cervical /vaginal smear, communicable disease diagnosis, diagnosis design /evaluation, fluorescence spectrometry, human papillomavirus artificial intelligence, histopathology, staining biopsy, cell line, fluorescent in situ hybridization, human tissue, immunofluorescence technique

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----